Ensuring that antibiotics are used correctly
Commonwealth Testing Limited (CT-DxTM) is in the process of developing a new generation of point-of-care (POC) diagnostic assays to ensure that antibiotics are only used when absolutely necessary.
Today, one of the greatest challenges in modern medicine is to prevent resistance by the human body to antibiotics. This growing problem is a global issue and CT-Dx wants to be part of the solution, by assisting medical professionals in only prescribing antibiotics when truly required.
Our assay platform is easy-to-use and affordable - important considerations for the global healthcare market. We aim to make robust diagnostic assays for use anywhere in the world, with reliable and precise diagnostic results in just a few minutes.
Diagnostic intelligence. Simplified.